At the time of exit, Creganna was a leading global provider of outsourced solutions to medical device manufacturers.

The company specialised in the design and manufacturing of delivery devices for less invasive surgical procedures, providing a complete range of solutions to assist medical device and life science companies to take products from concept design to full scale production.

Under the Permira funds' ownership, Creganna was transformed from a regional player to a leading global contract manufacturer with locations in Ireland, the US, Costa Rica and Singapore, serving the world’s leading medical device companies.